Royalty Pharma plc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$144.3M
37 notices · 3,147,012 sh
Oct 2025 to Oct 2026
Reported ·
$71.5M
61 sales · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
All 61 reported sales carry the 10b5-1 box.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-10-05Urist Marshall, EVP, Research & Investments$235,595
2026-09-28Urist Marshall, EVP, Research & Investments$238,813
2026-09-22SCH Investment Partners LLC, Officer$5,846,972
2026-08-18SCH Investment Partners LLC, Officer$6,012,000
2026-08-13Terrance Coyne, EVP & CFO$644,277
2026-08-12Errol B. De Souza, Former Affiliate$11.9M
2026-08-12Errol B. De Souza, Former Affiliate$7,223,750
2026-07-01Urist Marshall, EVP, Research & Investments$508,454
2026-06-30SCH Investment Partners LLC, Officer$5,709,000
2026-06-24Urist Marshall, EVP, Research & Investments$502,067
Form 4, 2026-06-25: sold 9,098 at $55.18All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on February 12, 2026. Form 4 ↗
2026-06-23Christopher Hite, EVP & Chairman, Partnering$1,660,500
Form 4, 2026-06-25: sold 150,000 at $54.39All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on March 20, 2026. Form 4 ↗
2026-06-23SCH Investment Partners LLC, Officer$8,166,766
2026-05-26Terrance Coyne, EVP & CFO$3,468,530
Form 4, 2026-05-28: sold 64,399 at $53.98All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on February 24, 2026. Form 4 ↗
2026-05-20Urist Marshall, EVP, Research & Investments$721,837
Form 4, 2026-05-21: sold 13,684 at $52.75All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on February 12, 2026. Form 4 ↗
2026-05-14Norden Gregory, Officer$161,385
Form 4, 2026-05-15: sold 3,045 at $53.00The reported transaction was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on February 12, 2026. Form 4 ↗
2026-05-14Urist Marshall, EVP, Research & Investments$726,138
Form 4, 2026-05-15: sold 13,684 at $53.06 Form 4 ↗
2026-04-28Terrance Coyne, EVP & CFO$1,723,546
Form 4, 2026-04-30: sold 34,791 at $49.78 Form 4 ↗
2026-04-01Terrance Coyne, EVP & CFO$1,687,016
Form 4, 2026-04-02: sold 34,791 at $48.33 Form 4 ↗
2026-03-23Terrance Coyne, EVP & CFO$1,586,818
Form 4, 2026-03-25: sold 34,791 at $45.53 Form 4 ↗
2026-03-19George Lloyd, EVP, Investments & CLO$1,662,665
2026-03-18George Lloyd, EVP, Investments & CLO$4,600,155
2026-03-04George Lloyd, EVP, Investments & CLO$6,496,961
2026-03-02Terrance Coyne, EVP & CFO$1,651,529
Form 4, 2026-03-04: sold 34,791 at $46.78 Form 4 ↗
2026-02-23Terrance Coyne, EVP & CFO$1,581,947
Form 4, 2026-02-25: sold 34,791 at $45.32 Form 4 ↗
2026-02-03Terrance Coyne, EVP & CFO$5,805,977
2026-02-02Terrance Coyne, EVP & CFO$4,592,841
Form 4, 2026-02-04: sold 243,541 at $42.54 Form 4 ↗
2026-01-20Terrance Coyne, EVP & CFO$2,719,960
Form 4, 2026-01-23: sold 69,582 at $39.35 Form 4 ↗
2026-01-07George Lloyd, EVP, Investments & CLO$20.5M
2026-01-02Terrance Coyne, EVP & CFO$2,703,957
Form 4, 2026-01-06: sold 69,582 at $38.42 Form 4 ↗
2025-12-16Sandy Lamm LLC, Officer$6,137,600
2025-12-15Terrance Coyne, EVP & CFO$2,680,994
Form 4, 2025-12-17: sold 69,582 at $38.36 Form 4 ↗
2025-12-01Urist Marshall, EVP, Research & Investments$1,455,712
Form 4, 2025-12-03: sold 41,575 at $39.92 Form 4 ↗
2025-12-01Terrance Coyne, EVP & CFO$2,776,322
Form 4, 2025-12-03: sold 69,582 at $39.87 Form 4 ↗
2025-12-01Sandy Lamm LLC, Officer$930,232
2025-11-24Terrance Coyne, EVP & CFO$2,765,885
Form 4, 2025-11-26: sold 69,582 at $38.55 Form 4 ↗
2025-11-19George Lloyd, EVP, Investments & CLO$13.7M
Form 4, 2025-11-21: sold 135,426 at $38.34 Form 4 ↗